N-myristoyltransferases inhibitory activity of ellagitannins from Terminalia bentzoe (L.) L. f. subsp. bentzoe.

Acyltransferases/antagonists & inhibitors; Cell Line, Tumor; France; Humans; Hydrolyzable Tannins/isolation & purification/pharmacology; Molecular Structure; Phytochemicals/isolation & purification/pharmacology; Plant Bark/chemistry; Plasmodium falciparum/drug effects; Reunion; Terminalia/chemistry; Combretaceae; Ellagitannins; Isoterchebulin; N-myristoyltransferase; Punicalagin; Terminalia bentzoe subsp. bentzoe

Abstract :

[en] N-myristoylation (Myr) is an eukaryotic N-terminal co- or post-translational protein modification in which the enzyme N-myristoyltransferase (NMT) transfers a fatty acid (C14:0) to the N-terminal glycine residues of several cellular key proteins. Depending on the cellular context, NMT may serve as a molecular target in anticancer or anti-infectious therapy, and drugs that inhibit this enzyme may be useful in the treatment of cancer or infectious diseases. As part of an on-going project to identify natural Homo sapiens N-myristoyltransferase 1 inhibitors (HsNMT1), two ellagitannins, punicalagin (1) and isoterchebulin (2), along with eschweilenol C (3) and ellagic acid (4) were isolated from the bark of Terminalia bentzoe (L.) L. f. subsp. bentzoe. Their structures were determined by means of spectroscopic analyses and comparison with literature data. Punicalagin (1) and isoterchebulin (2) showed significant inhibitory activity towards HsNMT1, and also against Plasmodium falciparum NMT (PfNMT) both in vitro and in cellulo, opening alternative paths for new NMT inhibitors development. This is the first report identifying natural products from a botanical source as inhibitors of HsNMT and PfNMT.

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Apel, Cecile

Bignon, Jerome

Garcia-Alvarez, Maria Concepcion

Ciccone, Sarah

Clerc, Patricia

Grondin, Isabelle

Girard-Valenciennes, Emmanuelle

Smadja, Jacqueline

Lopes, Philippe

Frederich, Michel ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie

More authors (4 more)

Language :

English

Title :

N-myristoyltransferases inhibitory activity of ellagitannins from Terminalia bentzoe (L.) L. f. subsp. bentzoe.

Publication date :

2018

Journal title :

Fitoterapia

ISSN :

0367-326X

Publisher :

Elsevier, Netherlands

Volume :

131

Pages :

91-95

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 16 January 2019

Statistics

Number of views

46 (2 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Gordon, J.I., Duronio, R.J., Rudnick, D.A., Adams, S.P., Gokel, G.W., Protein N-myristoylation. J. Biol. Chem. 266 (1991), 8647–8650 http://www.jbc.org/content/266/14/8647.full.pdf?sid=a9bfcbdf-add2-476c-9c1f-9015d27bdff8.
Boutin, J.A., Myristoylation. Cell. Signal. 9 (1997), 15–35, 10.1016/S0898-6568(96)00100-3.
Farazi, T.A., Waksman, G., Gordon, J.I., The biology and enzymology of protein N-myristoylation. J. Biol. Chem. 276 (2001), 39501–39504, 10.1074/jbc.R100042200.
Resh, M.D., Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. BBA-Mol. Cell Res. 1451 (1999), 1–16, 10.1016/S0167-4889(99)00075-0.
Resh, M.D., Trafficking and signaling by fatty-acylated and prenylated proteins. Nat. Chem. Biol. 2 (2006), 584–590, 10.1038/nchembio834.
Thinon, E., Morales-Sanfrutos, J., Mann, D.J., Tate, E.W., N-myristoyltransferase inhibition induces ER-stress, cell cycle arrest, and apoptosis in cancer cells. ACS Chem. Biol. 11 (2016), 2165–2217, 10.1021/acschembio.6b00371.
Wright, M.H., Heal, W.P., Mann, D.J., Tate, E.W., Protein myristoylation in health and disease. J. Chem. Biol. 3 (2010), 19–35, 10.1007/s12154-009-0032-8.
Das, U., Kumar, S., R. Dimmock, J., K. Sharma, R., Inhibition of Protein N-myristoylation: A therapeutic protocol in developing anticancer agents. Curr. Cancer Drug Targets 12 (2012), 667–692, 10.2174/156800912801784857.
Felsted, R.L., Glover, C.J., Hartman, K., Protein N-myristoylation as a chemotherapeutic target for cancer. J. Nat. Cancer I. 87 (1995), 1571–1573, 10.1093/jnci/87.21.1571.
Selvakumar, P., Lakshmikuttyamma, A., Shrivastav, A., Das, S.B., Dimmock, J.R., Sharma, R.K., Potential role of N-myristoyltransferase in cancer. Progr. Lipid Res. 46 (2007), 1–36, 10.1016/j.plipres.2006.05.002.
Zhao, C., Ma, S., Recent advances in the discovery of N-myristoyltransferase inhibitors. ChemMedChem 9 (2017), 2425–2437, 10.1002/cmdc.201402174.
Furuishia, K., Matsuokaa, H., Takamab, M., Takahashib, I., Misumia, S., Shoji, S., Blockage of N-myristoylation of HIV-1 Gag induces the production of potent progeny virus. Biochem. Biophys. Res. Commun. 237 (1997), 504–511, 10.1006/bbrc.1997.7178.
Hill, B.T., Skowronski, J., Human N-myristoyltransferases form stable complexes with lentiviral Nef and other viral and cellular substrate proteins. J. Virol. 79 (2005), 1133–1141, 10.1128/JVI.79.2.1133-1141.2005.
Seaton, K.E., Smith, C.D., N-Myristoyltransferase isozymes exhibit differential specificity for human immunodeficiency virus type 1 Gag and Nef. J. Gen. Virol. 89 (2008), 288–296, 10.1099/vir.0.83412-0.
Georgopapadakou, N.H., Antifungals targeted to protein modification: focus on protein N-myristoyltransferase. Expert Opin. Investig. Drugs 11 (2002), 1117–1125, 10.1517/13543784.11.8.1117.
Frearson, J.A., Brand, S., McElroy, S.P., Cleghorn, L.A., Smid, O., Stojanovski, L., Price, H.P., Guther, M.L., Torrie, L.S., Robinson, D.A., Hallyburton, I., Mpamhanga, C.P., Brannigan, J.A., Wilkinson, A.J., Hodgkinson, M., Hui, R., Qiu, W., Raimi, O.G., van Aalten, D.M., Brenk, R., Gilbert, I.H., Read, K.D., Fairlamb, A.H., Ferguson, M.A., Smith, D.F., Wyatt, P.G., N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature 464 (2010), 728–732, 10.1038/nature08893.
Tate, E.W., Bell, A.S., Rackham, M.D., Wright, M.H., N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis. Parasitology 141 (2014), 37–49, 10.1017/S0031182013000450.
Wright, M.H., Clough, B., Rackham, M.D., Rangachari, K., Brannigan, J.A., Grainger, M., Moss, D.K., Bottrill, A.R., Heal, W.P., Broncel, M., Serwa, R.A., Brady, D., Mann, D.J., Leatherbarrow, R.J., Tewari, R., Wilkinson, A.J., Holder, A.A., Tate, E.W., Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach. Nat. Chem. 6 (2013), 112–121, 10.1038/nchem.1830.
Traverso, J.A., Giglione, C., Meinnel, T., High-throughput profiling of N-myristoylation substrate specificity across species including pathogens. Proteomics 13 (2013), 25–36, 10.1002/pmic.201200375.
Ritzefeld, M., Wright, M.H., Tate, E.W., New developments in probing and targeting protein acylation in malaria, leishmaniasis and African sleeping sickness. Parasitology 145 (2018), 157–174, 10.1017/S0031182017000282.
The Plant List, Version 1.1. Retrieved from http://www.theplantlist.org/, 2013 (accessed Aug. 06, 2018).
Cock, I.E., The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacology 23 (2015), 203–229, 10.1007/s10787-015-0246-z.
Mascarine Cadetiana (n.d.). Retrieved from https://mascarine.cbnm.org/.
Lavergne, R., Tisaneurs et plantes médicinales indigènes. 1990, Livry-Gargan, Editions Orphie (ISBN : 2-8776-3005-X).
Jonville, M.C., Kodja, H., Strasberg, D., Pichette, A., Ollivier, E., Frederich, M., Angenot, L., Legault, J., Antiplasmodial, anti-inflammatory and cytotoxic activities of various plant extracts from the Mascarene Archipelago. J. Ethnopharmacol. 136 (2011), 525–531, 10.1016/j.jep.2010.06.013.
Trager, W., Jensen, J.B., Human malaria parasites in continuous culture. Science 193 (1976), 673–675, 10.1645/0022-3395(2005)091%5B0484:HMPICC%5D2.0.CO;2.
Muganga, R., Angenot, L., Tits, M., Frederich, M., In vitro and in vivo antiplasmodial activity of three Rwandan medicinal plants and identification of their active compounds. Planta Med. 80 (2014), 482–489, 10.1055/s-0034-1368322.
Kraszni, M., Marosi, A., Larive, C.K., NMR assignments and the acid-base characterization of the pomegranate ellagitannin punicalagin in the acidic pH-range. Anal. Bioanal. Chem. 405 (2013), 5807–5816, 10.1007/s00216-013-6987-x.
Tanaka, T., Nonaka, G.I., Nishioka, I., Tannins and related compounds. XL. Revision of the structure of punicalin and punicalagin, and isolation and characterization of 2-O-galloylpunicalin from the bark of Punica granatum L. Chem. Pharm. Bull. 34 (1986), 650–655, 10.1248/cpb.34.650.
Doig, A.J., Williams, D.H., Oelrichs, P.B., Baczynskyj, L., Isolation and structure elucidation of punicalagin, a toxic hydrolysable tannin, from Terminalia oblongata. J. Chem. Soc. Perkin Trans. 1:8 (1990), 2317–2321, 10.1039/P19900002317.
Jossang, A., Pousset, J.L., Bodo, B., Combreglutinin, a hydrolyzable tannin from Combretum Glutinosum. J. Nat. Prod. 57 (1994), 732–737, 10.1021/np50108a008.
Tanaka, T., Nonaka, G.I., Nishioka, I., Tannins and related compounds. XLII. Isolation and characterization of four new hydrolyzable tannins, terflavins A and B, tergallagin and tercatain from the leaves of Terminalia catappa L. Chem. Pharm. Bull. 34 (1986), 1039–1049, 10.1248/cpb.34.1039.
Lin, T.C., Nonaka, G.I., Nishioka, I., Ho, F.C., Tannins and related compounds. CII. Structures of terchebulin, an ellagitannin having a novel tetraphenylcarboxylic acid (terchebulic acid) moiety, and biogenetically related tannins from Terminalia chebula Retz. Chem. Pharm. Bull. 38 (1990), 3004–3008, 10.1248/cpb.38.3004.
Conrad, J., Vogler, B., Reeb, S., Klaiber, I., Papajewski, S., Roos, G., Vasquez, E., Setzer, M.C., Kraus, W., Isoterchebulin and 4,6-O-isoterchebuloyl-D-glucose, novel hydrolyzable tannins from Terminalia macroptera. J. Nat. Prod. 64 (2001), 294–299, 10.1021/np000506v.
Yang, S.W., Zhou, B.N., Wisse, J.H., Evans, R., van der Werff, H., Miller, J.S., Kingston, D.G., Three new ellagic acid derivatives from the bark of Eschweilera coriacea from the Suriname rainforest. J. Nat. Prod. 61 (1998), 901–906, 10.1021/np980046u.
Li, X.C., Elsohly, H.N., Hufford, C.D., Clark, A.M., NMR assignments of ellagic acid derivatives. Magn. Reson. Chem. 37 (1999), 856–859, 10.1002/(SICI)1097-458X(199911)37:11<856::AID-MRC529>3.0.CO;2-X.
Quideau, S., Chemistry and BIOLOGY of Ellagitannins. An Underestimated Class of Bioactive Plant Polyphenols. 2009, World Scientific Publishing Co Pte Ltd.
Reddy, M.K., Gupta, S.K., Jacob, M.R., Khan, S.I., Ferreira, D., Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med. 73 (2007), 461–467, 10.1055/s-2007-967167.
Asres, K., Bucar, F., Knauder, E., Yardley, V., Kendrick, H., Croft, S.L., In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytother. Res. 15 (2001), 613–617, 10.1002/ptr.897.